Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinshan Nuclear Power Plant, located in Zhejiang Province, China, is a major nuclear power generation facility that has emerged as a critical supplier for the global life sciences and healthcare industries. Operated by the China National Nuclear Corporation (CNNC), the plant utilizes its heavy water reactors to produce a variety of essential medical isotopes, including Cobalt-60, Carbon-14, and Lutetium-177. These isotopes are fundamental to medical sterilization, diagnostic breath tests, and the development of targeted radiopharmaceuticals for cancer treatment. By leveraging its industrial nuclear infrastructure for medical applications, Qinshan plays a pivotal role in the radiopharmaceutical supply chain, particularly in reducing China's reliance on imported medical isotopes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinshan Nuclear Power Plant.